Balo, Jude Jairo .

HRN: 25-47-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2025
CEFUROXIME 750MG (VIAL)
02/19/2025
02/26/2025
IV
300mg
Q8
UTI
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractBloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: